Loading…

Comparison of short- and mid-term outcomes between CYPHER and TAXUS stents in patients with complex lesions of the coronary arteries

Background Drug-eluting stent (DES) could obviously reduce in-stent restenosis, which has been proved by international multi-center clinical trials. However, the types of the lesions for stenting were highly selected in these trials. Up to now, there has been no large scale study on the effect of DE...

Full description

Saved in:
Bibliographic Details
Published in:Chinese medical journal 2006-01, Vol.119 (1), p.21-25
Main Authors: Chen, Ji-lin, Gao, Run-lin, Yang, Yue-jin, Qiao, Shu-bing, Qin, Xue-wen, Yao, Min, Liu, Hai-bo, Xu, Bo, Wu, Yong-jian, Yuan, Jin-qing, Chen, Jue, Dai, Jun, You, Shi-jie, Ma, Wei-hua
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c421t-ba185a4f5ed9671dae2465672bddae67e7b766af37ac1ad953e7dfa5baf79ae3
cites cdi_FETCH-LOGICAL-c421t-ba185a4f5ed9671dae2465672bddae67e7b766af37ac1ad953e7dfa5baf79ae3
container_end_page 25
container_issue 1
container_start_page 21
container_title Chinese medical journal
container_volume 119
creator Chen, Ji-lin
Gao, Run-lin
Yang, Yue-jin
Qiao, Shu-bing
Qin, Xue-wen
Yao, Min
Liu, Hai-bo
Xu, Bo
Wu, Yong-jian
Yuan, Jin-qing
Chen, Jue
Dai, Jun
You, Shi-jie
Ma, Wei-hua
description Background Drug-eluting stent (DES) could obviously reduce in-stent restenosis, which has been proved by international multi-center clinical trials. However, the types of the lesions for stenting were highly selected in these trials. Up to now, there has been no large scale study on the effect of DES in treating complex lesions in real world. Although REALITY trial was just reported during American College of Cardiology Congress 2005, the entry criteria for lesions were limited to one or two de novo lesions. This study was conducted to compare the short- and mid-term clinical outcomes between sirolimus-eluting stent (CYPHER stent) and paclitaxel-eluting stent (TAXUS stent) in patients with complex lesion. Methods This is a retrospective study. From April 2002 to June 2004, a total of 1061 patients were treated with DES in Fu Wai Hospital, of which, 611 patients (642 lesions with 698 CYPHER stents) were in CYPHER group, and 450 patients (534 lesions with 600 TAXUS stents) were in TAXUS group. There was no significant difference in clinical data and lesion types between CYPHER group and TAXUS group. Results Success rates of stent implantation were 99.2% and 98.8% in CYPHER and TAXUS stent groups respectively. The major adverse cardiac events (MACE) during in-hospital and 6-8-month follow-up were 0.7% and 2.3% in CYPHER stent group versus 1.3% and 3.2% in TAXUS stent group. There was no significant difference in MACE rate between these two groups. Restenosis rate was a little higher in TAXUS stent group than that in CYPHER stent group (14.0% vs 7.3%), but there was no significant difference. The incidence of acute occlusion of side branch after implanting DES in main vessel was 6.9% in CYPHER group and 11.9% in TAXUS group (P〈0.05) . Conclusions CYPHER and TAXUS DES were safe and effective in patients with complex lesion. Clinical outcomes of CYPHER stent were better than TAXUS stent in bifurcation lesions. There was an increasing tendency in restenosis rate and late thrombosis in TAXUS group as compared with that of CYPHER group.
doi_str_mv 10.1097/00029330-200601010-00004
format article
fullrecord <record><control><sourceid>wanfang_jour_proqu</sourceid><recordid>TN_cdi_wanfang_journals_zhcmj200601004</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>21191449</cqvip_id><wanfj_id>zhcmj200601004</wanfj_id><sourcerecordid>zhcmj200601004</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-ba185a4f5ed9671dae2465672bddae67e7b766af37ac1ad953e7dfa5baf79ae3</originalsourceid><addsrcrecordid>eNpFkU9v1DAQxS0EokvhKyCLAzeDnfhPfaxWhSJVKoJFgpPlJJPGS2KntqMFznzwuttA5YNHo_fmjf1DCDP6jlGt3lNKK13XlFSUSsrKIaVF-RO0qQSviJCcPUUbWktJpNb6BL1IaV9MQij5HJ0wyQXXSm3Q322YZhtdCh6HHqchxEyw9R2eXEcyxAmHJbdhgoQbyAcAj7c_Pl9efDmKduffv33FKYPPCTuPZ5vdsT64POBim0f4hUdILvh0H5AHKO0YvI2_sY0lwEF6iZ71dkzwar1P0e7DxW57Sa6uP37anl-Rllcsk8ayM2F5L6DTUrHOQsWlkKpqulJLBapRUtq-VrZlttOiBtX1VjS2V9pCfYrePow9WN9bf2P2YYm-BJo_Qzvt17-k_FE4x3C7QMpmcqmFcbQewpKMVLLimskiPHsQtjGkFKE3c3RTeZph1NyTMv9Imf-kzJFUsb5eM5Zmgu7RuKIpgjfr7CH4m1tX9m1s-7N3I5iKMc041_UduYCbyw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67624916</pqid></control><display><type>article</type><title>Comparison of short- and mid-term outcomes between CYPHER and TAXUS stents in patients with complex lesions of the coronary arteries</title><source>HEAL-Link subscriptions: Lippincott Williams &amp; Wilkins</source><creator>Chen, Ji-lin ; Gao, Run-lin ; Yang, Yue-jin ; Qiao, Shu-bing ; Qin, Xue-wen ; Yao, Min ; Liu, Hai-bo ; Xu, Bo ; Wu, Yong-jian ; Yuan, Jin-qing ; Chen, Jue ; Dai, Jun ; You, Shi-jie ; Ma, Wei-hua</creator><creatorcontrib>Chen, Ji-lin ; Gao, Run-lin ; Yang, Yue-jin ; Qiao, Shu-bing ; Qin, Xue-wen ; Yao, Min ; Liu, Hai-bo ; Xu, Bo ; Wu, Yong-jian ; Yuan, Jin-qing ; Chen, Jue ; Dai, Jun ; You, Shi-jie ; Ma, Wei-hua</creatorcontrib><description>Background Drug-eluting stent (DES) could obviously reduce in-stent restenosis, which has been proved by international multi-center clinical trials. However, the types of the lesions for stenting were highly selected in these trials. Up to now, there has been no large scale study on the effect of DES in treating complex lesions in real world. Although REALITY trial was just reported during American College of Cardiology Congress 2005, the entry criteria for lesions were limited to one or two de novo lesions. This study was conducted to compare the short- and mid-term clinical outcomes between sirolimus-eluting stent (CYPHER stent) and paclitaxel-eluting stent (TAXUS stent) in patients with complex lesion. Methods This is a retrospective study. From April 2002 to June 2004, a total of 1061 patients were treated with DES in Fu Wai Hospital, of which, 611 patients (642 lesions with 698 CYPHER stents) were in CYPHER group, and 450 patients (534 lesions with 600 TAXUS stents) were in TAXUS group. There was no significant difference in clinical data and lesion types between CYPHER group and TAXUS group. Results Success rates of stent implantation were 99.2% and 98.8% in CYPHER and TAXUS stent groups respectively. The major adverse cardiac events (MACE) during in-hospital and 6-8-month follow-up were 0.7% and 2.3% in CYPHER stent group versus 1.3% and 3.2% in TAXUS stent group. There was no significant difference in MACE rate between these two groups. Restenosis rate was a little higher in TAXUS stent group than that in CYPHER stent group (14.0% vs 7.3%), but there was no significant difference. The incidence of acute occlusion of side branch after implanting DES in main vessel was 6.9% in CYPHER group and 11.9% in TAXUS group (P〈0.05) . Conclusions CYPHER and TAXUS DES were safe and effective in patients with complex lesion. Clinical outcomes of CYPHER stent were better than TAXUS stent in bifurcation lesions. There was an increasing tendency in restenosis rate and late thrombosis in TAXUS group as compared with that of CYPHER group.</description><identifier>ISSN: 0366-6999</identifier><identifier>EISSN: 2542-5641</identifier><identifier>DOI: 10.1097/00029330-200601010-00004</identifier><identifier>PMID: 16454977</identifier><language>eng</language><publisher>China: Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China</publisher><subject>Coronary Disease - therapy ; CYPHER ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Paclitaxel - administration &amp; dosage ; Retrospective Studies ; Sirolimus - administration &amp; dosage ; Stents - adverse effects ; TAXUS ; 冠状动脉 ; 复合物 ; 血管狭窄</subject><ispartof>Chinese medical journal, 2006-01, Vol.119 (1), p.21-25</ispartof><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-ba185a4f5ed9671dae2465672bddae67e7b766af37ac1ad953e7dfa5baf79ae3</citedby><cites>FETCH-LOGICAL-c421t-ba185a4f5ed9671dae2465672bddae67e7b766af37ac1ad953e7dfa5baf79ae3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/85656X/85656X.jpg</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16454977$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Ji-lin</creatorcontrib><creatorcontrib>Gao, Run-lin</creatorcontrib><creatorcontrib>Yang, Yue-jin</creatorcontrib><creatorcontrib>Qiao, Shu-bing</creatorcontrib><creatorcontrib>Qin, Xue-wen</creatorcontrib><creatorcontrib>Yao, Min</creatorcontrib><creatorcontrib>Liu, Hai-bo</creatorcontrib><creatorcontrib>Xu, Bo</creatorcontrib><creatorcontrib>Wu, Yong-jian</creatorcontrib><creatorcontrib>Yuan, Jin-qing</creatorcontrib><creatorcontrib>Chen, Jue</creatorcontrib><creatorcontrib>Dai, Jun</creatorcontrib><creatorcontrib>You, Shi-jie</creatorcontrib><creatorcontrib>Ma, Wei-hua</creatorcontrib><title>Comparison of short- and mid-term outcomes between CYPHER and TAXUS stents in patients with complex lesions of the coronary arteries</title><title>Chinese medical journal</title><addtitle>Chinese Medical Journal</addtitle><description>Background Drug-eluting stent (DES) could obviously reduce in-stent restenosis, which has been proved by international multi-center clinical trials. However, the types of the lesions for stenting were highly selected in these trials. Up to now, there has been no large scale study on the effect of DES in treating complex lesions in real world. Although REALITY trial was just reported during American College of Cardiology Congress 2005, the entry criteria for lesions were limited to one or two de novo lesions. This study was conducted to compare the short- and mid-term clinical outcomes between sirolimus-eluting stent (CYPHER stent) and paclitaxel-eluting stent (TAXUS stent) in patients with complex lesion. Methods This is a retrospective study. From April 2002 to June 2004, a total of 1061 patients were treated with DES in Fu Wai Hospital, of which, 611 patients (642 lesions with 698 CYPHER stents) were in CYPHER group, and 450 patients (534 lesions with 600 TAXUS stents) were in TAXUS group. There was no significant difference in clinical data and lesion types between CYPHER group and TAXUS group. Results Success rates of stent implantation were 99.2% and 98.8% in CYPHER and TAXUS stent groups respectively. The major adverse cardiac events (MACE) during in-hospital and 6-8-month follow-up were 0.7% and 2.3% in CYPHER stent group versus 1.3% and 3.2% in TAXUS stent group. There was no significant difference in MACE rate between these two groups. Restenosis rate was a little higher in TAXUS stent group than that in CYPHER stent group (14.0% vs 7.3%), but there was no significant difference. The incidence of acute occlusion of side branch after implanting DES in main vessel was 6.9% in CYPHER group and 11.9% in TAXUS group (P〈0.05) . Conclusions CYPHER and TAXUS DES were safe and effective in patients with complex lesion. Clinical outcomes of CYPHER stent were better than TAXUS stent in bifurcation lesions. There was an increasing tendency in restenosis rate and late thrombosis in TAXUS group as compared with that of CYPHER group.</description><subject>Coronary Disease - therapy</subject><subject>CYPHER</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Paclitaxel - administration &amp; dosage</subject><subject>Retrospective Studies</subject><subject>Sirolimus - administration &amp; dosage</subject><subject>Stents - adverse effects</subject><subject>TAXUS</subject><subject>冠状动脉</subject><subject>复合物</subject><subject>血管狭窄</subject><issn>0366-6999</issn><issn>2542-5641</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNpFkU9v1DAQxS0EokvhKyCLAzeDnfhPfaxWhSJVKoJFgpPlJJPGS2KntqMFznzwuttA5YNHo_fmjf1DCDP6jlGt3lNKK13XlFSUSsrKIaVF-RO0qQSviJCcPUUbWktJpNb6BL1IaV9MQij5HJ0wyQXXSm3Q322YZhtdCh6HHqchxEyw9R2eXEcyxAmHJbdhgoQbyAcAj7c_Pl9efDmKduffv33FKYPPCTuPZ5vdsT64POBim0f4hUdILvh0H5AHKO0YvI2_sY0lwEF6iZ71dkzwar1P0e7DxW57Sa6uP37anl-Rllcsk8ayM2F5L6DTUrHOQsWlkKpqulJLBapRUtq-VrZlttOiBtX1VjS2V9pCfYrePow9WN9bf2P2YYm-BJo_Qzvt17-k_FE4x3C7QMpmcqmFcbQewpKMVLLimskiPHsQtjGkFKE3c3RTeZph1NyTMv9Imf-kzJFUsb5eM5Zmgu7RuKIpgjfr7CH4m1tX9m1s-7N3I5iKMc041_UduYCbyw</recordid><startdate>20060105</startdate><enddate>20060105</enddate><creator>Chen, Ji-lin</creator><creator>Gao, Run-lin</creator><creator>Yang, Yue-jin</creator><creator>Qiao, Shu-bing</creator><creator>Qin, Xue-wen</creator><creator>Yao, Min</creator><creator>Liu, Hai-bo</creator><creator>Xu, Bo</creator><creator>Wu, Yong-jian</creator><creator>Yuan, Jin-qing</creator><creator>Chen, Jue</creator><creator>Dai, Jun</creator><creator>You, Shi-jie</creator><creator>Ma, Wei-hua</creator><general>Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope></search><sort><creationdate>20060105</creationdate><title>Comparison of short- and mid-term outcomes between CYPHER and TAXUS stents in patients with complex lesions of the coronary arteries</title><author>Chen, Ji-lin ; Gao, Run-lin ; Yang, Yue-jin ; Qiao, Shu-bing ; Qin, Xue-wen ; Yao, Min ; Liu, Hai-bo ; Xu, Bo ; Wu, Yong-jian ; Yuan, Jin-qing ; Chen, Jue ; Dai, Jun ; You, Shi-jie ; Ma, Wei-hua</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-ba185a4f5ed9671dae2465672bddae67e7b766af37ac1ad953e7dfa5baf79ae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Coronary Disease - therapy</topic><topic>CYPHER</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Paclitaxel - administration &amp; dosage</topic><topic>Retrospective Studies</topic><topic>Sirolimus - administration &amp; dosage</topic><topic>Stents - adverse effects</topic><topic>TAXUS</topic><topic>冠状动脉</topic><topic>复合物</topic><topic>血管狭窄</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Ji-lin</creatorcontrib><creatorcontrib>Gao, Run-lin</creatorcontrib><creatorcontrib>Yang, Yue-jin</creatorcontrib><creatorcontrib>Qiao, Shu-bing</creatorcontrib><creatorcontrib>Qin, Xue-wen</creatorcontrib><creatorcontrib>Yao, Min</creatorcontrib><creatorcontrib>Liu, Hai-bo</creatorcontrib><creatorcontrib>Xu, Bo</creatorcontrib><creatorcontrib>Wu, Yong-jian</creatorcontrib><creatorcontrib>Yuan, Jin-qing</creatorcontrib><creatorcontrib>Chen, Jue</creatorcontrib><creatorcontrib>Dai, Jun</creatorcontrib><creatorcontrib>You, Shi-jie</creatorcontrib><creatorcontrib>Ma, Wei-hua</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>维普中文期刊数据库</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><jtitle>Chinese medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Ji-lin</au><au>Gao, Run-lin</au><au>Yang, Yue-jin</au><au>Qiao, Shu-bing</au><au>Qin, Xue-wen</au><au>Yao, Min</au><au>Liu, Hai-bo</au><au>Xu, Bo</au><au>Wu, Yong-jian</au><au>Yuan, Jin-qing</au><au>Chen, Jue</au><au>Dai, Jun</au><au>You, Shi-jie</au><au>Ma, Wei-hua</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of short- and mid-term outcomes between CYPHER and TAXUS stents in patients with complex lesions of the coronary arteries</atitle><jtitle>Chinese medical journal</jtitle><addtitle>Chinese Medical Journal</addtitle><date>2006-01-05</date><risdate>2006</risdate><volume>119</volume><issue>1</issue><spage>21</spage><epage>25</epage><pages>21-25</pages><issn>0366-6999</issn><eissn>2542-5641</eissn><abstract>Background Drug-eluting stent (DES) could obviously reduce in-stent restenosis, which has been proved by international multi-center clinical trials. However, the types of the lesions for stenting were highly selected in these trials. Up to now, there has been no large scale study on the effect of DES in treating complex lesions in real world. Although REALITY trial was just reported during American College of Cardiology Congress 2005, the entry criteria for lesions were limited to one or two de novo lesions. This study was conducted to compare the short- and mid-term clinical outcomes between sirolimus-eluting stent (CYPHER stent) and paclitaxel-eluting stent (TAXUS stent) in patients with complex lesion. Methods This is a retrospective study. From April 2002 to June 2004, a total of 1061 patients were treated with DES in Fu Wai Hospital, of which, 611 patients (642 lesions with 698 CYPHER stents) were in CYPHER group, and 450 patients (534 lesions with 600 TAXUS stents) were in TAXUS group. There was no significant difference in clinical data and lesion types between CYPHER group and TAXUS group. Results Success rates of stent implantation were 99.2% and 98.8% in CYPHER and TAXUS stent groups respectively. The major adverse cardiac events (MACE) during in-hospital and 6-8-month follow-up were 0.7% and 2.3% in CYPHER stent group versus 1.3% and 3.2% in TAXUS stent group. There was no significant difference in MACE rate between these two groups. Restenosis rate was a little higher in TAXUS stent group than that in CYPHER stent group (14.0% vs 7.3%), but there was no significant difference. The incidence of acute occlusion of side branch after implanting DES in main vessel was 6.9% in CYPHER group and 11.9% in TAXUS group (P〈0.05) . Conclusions CYPHER and TAXUS DES were safe and effective in patients with complex lesion. Clinical outcomes of CYPHER stent were better than TAXUS stent in bifurcation lesions. There was an increasing tendency in restenosis rate and late thrombosis in TAXUS group as compared with that of CYPHER group.</abstract><cop>China</cop><pub>Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China</pub><pmid>16454977</pmid><doi>10.1097/00029330-200601010-00004</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0366-6999
ispartof Chinese medical journal, 2006-01, Vol.119 (1), p.21-25
issn 0366-6999
2542-5641
language eng
recordid cdi_wanfang_journals_zhcmj200601004
source HEAL-Link subscriptions: Lippincott Williams & Wilkins
subjects Coronary Disease - therapy
CYPHER
Female
Follow-Up Studies
Humans
Male
Middle Aged
Paclitaxel - administration & dosage
Retrospective Studies
Sirolimus - administration & dosage
Stents - adverse effects
TAXUS
冠状动脉
复合物
血管狭窄
title Comparison of short- and mid-term outcomes between CYPHER and TAXUS stents in patients with complex lesions of the coronary arteries
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T23%3A40%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20short-%20and%20mid-term%20outcomes%20between%20CYPHER%20and%20TAXUS%20stents%20in%20patients%20with%20complex%20lesions%20of%20the%20coronary%20arteries&rft.jtitle=Chinese%20medical%20journal&rft.au=Chen,%20Ji-lin&rft.date=2006-01-05&rft.volume=119&rft.issue=1&rft.spage=21&rft.epage=25&rft.pages=21-25&rft.issn=0366-6999&rft.eissn=2542-5641&rft_id=info:doi/10.1097/00029330-200601010-00004&rft_dat=%3Cwanfang_jour_proqu%3Ezhcmj200601004%3C/wanfang_jour_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c421t-ba185a4f5ed9671dae2465672bddae67e7b766af37ac1ad953e7dfa5baf79ae3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67624916&rft_id=info:pmid/16454977&rft_cqvip_id=21191449&rft_wanfj_id=zhcmj200601004&rfr_iscdi=true